How to Value an OB/GYN Practice in 2026

OB/GYN practice valuation sits at the intersection of healthcare M&A's trickiest dynamics: high malpractice exposure, complex payer mix, call coverage logistics, and the fundamental question of whether the practice is primarily obstetric, primarily gynecologic, or a true split. Each configuration values differently, and buyers know it.

I've advised on OB/GYN transactions where identical revenue numbers produced valuations that differed by 50% because of what was underneath those numbers. Let me walk you through what actually drives value in this specialty.

The Multiple Range: 3-7x EBITDA

OB/GYN practices typically trade at 3-7x EBITDA, a wider range than most medical specialties. The low end represents small, OB-heavy practices with high malpractice costs and call burden that make recruitment difficult. The high end represents established GYN-dominant or balanced practices with strong surgical volume, modern ultrasound capabilities, and hospital system or PE interest.

For solo practitioners or small groups selling to another physician, the valuation often collapses to an SDE-based framework at 1.5-3x SDE. The buyer is purchasing a job, and the price needs to make sense relative to what they'll earn after debt service. But when health systems or PE-backed platforms are at the table, EBITDA-based pricing takes over and the numbers move substantially.

Delivery Volume: The OB Factor

Obstetric delivery volume is one of the most nuanced value drivers in all of healthcare M&A. On the surface, more deliveries means more revenue. But buyers look deeper.

A practice delivering 200-300 babies per physician per year is in the sweet spot. Below 150, and buyers question whether the OB revenue justifies the malpractice premium and call burden. Above 350 per physician, and buyers worry about burnout, quality risk, and whether volume will decline when the selling physician leaves.

The composition of deliveries matters as much as volume. Practices with a healthy mix of vaginal deliveries and C-sections (the national average is roughly 32% C-section) are viewed as clinically balanced. A practice with a C-section rate well above 40% raises questions about clinical decision-making that can spook hospital-affiliated buyers. A rate well below 20% in a mixed-risk population might signal under-coding or a patient population that skews low-risk and low-reimbursement.

The trend line matters more than the snapshot.Declining delivery volume over three years tells a buyer that referring physicians are sending patients elsewhere, or that the practice isn't keeping up with younger competitors. Stable or growing volume, even if modest, signals a healthy referral network.

Ultrasound and Ancillary Revenue

In-office ultrasound is the single most important ancillary revenue stream in OB/GYN, and its presence (or absence) meaningfully impacts valuation. A practice with a modern ultrasound suite performing OB imaging, gynecologic diagnostic scans, and elective 3D/4D imaging can generate $150,000-$400,000 in annual ancillary revenue depending on volume.

Buyers evaluate ultrasound capability on three dimensions:

• Equipment quality: GE Voluson or Samsung systems less than 5 years old are assets. Older equipment means a $75,000-$150,000 capital outlay for the buyer.
• Credentialing and accreditation: AIUM-accredited ultrasound programs command higher reimbursement and signal quality to hospital and PE buyers.
• Capture rate: What percentage of OB patients receive their imaging in-house versus being referred out? A practice referring 40% of imaging to a hospital radiology department is leaving revenue — and valuation — on the table.

Beyond ultrasound, other ancillary streams that add value include in-office lab work (CBC, urinalysis, STI panels), bone density scanning for menopausal patients, and cosmetic GYN procedures. Each stream that stays in-house rather than being referred out increases both revenue and margin.

Surgical Capability and ASC Access

Gynecologic surgical volume is a major differentiator. Practices performing minimally invasive GYN surgery — laparoscopic hysterectomy, robotic-assisted procedures, endometrial ablation, and office-based hysteroscopy — generate significantly higher revenue per provider and attract premium multiples.

The key question buyers ask: where are surgeries performed? Practices with access to an ambulatory surgery center (ASC) rather than relying solely on hospital operating rooms have better economics. ASC cases have lower facility fees, faster turnover, and higher physician reimbursement. If the practice owns equity in an ASC, that's a separate and potentially very valuable asset.

Office-based procedures are increasingly important. Endometrial ablation, hysteroscopic sterilization, and LEEP procedures performed in the office generate better margins than the same procedures in a surgical facility. Practices that have invested in the equipment and workflow to shift appropriate cases to the office setting demonstrate operational sophistication that buyers reward.

Call Coverage: The Hidden Cost That Drives Deals

Call coverage structure is uniquely important in OB/GYN because delivering babies requires 24/7 availability. How a practice manages call directly affects physician recruitment, retention, and therefore the sustainability of the business after a sale.

Solo OB/GYN practices face the harshest valuation discount. A single physician covering their own call is a practice that collapses entirely when that physician leaves. Buyers know that the first thing they need to do is hire a second provider, and that hire comes with a $350,000-$450,000 annual cost before they see a single additional patient.

Groups of 3-4 physicians with a structured call rotation are the sweet spot for buyers. The call burden is manageable (1-in-3 or 1-in-4), the practice can absorb one departure without crisis, and the economics support the overhead. This is where you see the 5-7x EBITDA multiples.

Laborist models — where the practice uses hospitalist OBs for after-hours deliveries — are increasingly common and valued by buyers. They reduce burnout, improve physician satisfaction, and make recruitment easier. If your hospital offers a laborist program and your practice participates, highlight this prominently when marketing the practice.

Malpractice: The Cost That Defines OB/GYN

Malpractice insurance is the defining expense of OB/GYN practice. Annual premiums range from $50,000 per physician in low-risk states to $200,000+ in states like New York, Florida, and Illinois. These costs flow directly through to EBITDA and can make or break a practice's attractiveness to buyers.

Buyers evaluate malpractice exposure on several dimensions. Claims history is paramount — a practice with multiple open claims or a recent large settlement will see its multiple compressed by 1-2 turns. Tail coverage obligationsmust be addressed in the transaction structure. The selling physician's tail policy (covering claims arising from care provided before the sale) can cost $75,000-$200,000, and who pays for it is always a negotiation point.

Some practices have shifted to GYN-only models specifically to escape obstetric malpractice costs. A GYN-only practice with strong surgical volume can generate comparable revenue with 40-60% lower malpractice premiums. These practices value at the higher end of the range because the margin improvement flows straight to EBITDA.

Hospital Affiliation and Health System Interest

Hospital systems have been the most active acquirers of OB/GYN practices over the past decade, and for good reason. Obstetrics is a strategic priority for hospitals because deliveries drive downstream pediatric, NICU, and women's health revenue. A hospital that loses its OB/GYN referral base risks losing an entire service line.

This dynamic creates a premium for practices that are strategically important to a hospital system. If your practice accounts for a significant share of deliveries at a particular hospital, that hospital has a strong incentive to acquire you rather than risk losing you to a competitor. I've seen this strategic premium add 1-2 EBITDA turns to a deal.

Existing hospital affiliations — medical directorships, teaching appointments, exclusive on-call arrangements — can be both value drivers and complications. They signal prestige and integration, but they can also create non-compete and contractual entanglements that limit the buyer pool. If you hold hospital contracts, have your M&A attorney review them for assignment and termination provisions well before going to market.

What Maximizes OB/GYN Practice Value

If you're 2-3 years from a sale, focus on these high-impact moves:

Bring imaging in-house.Every ultrasound referral sent to an outside facility is revenue and margin you're giving away. Investing in equipment and AIUM accreditation pays for itself in 12-18 months and adds permanent value.

Shift appropriate surgeries to office-based settings. The margin improvement from performing hysteroscopies and ablations in-office rather than at the hospital is substantial, and it signals operational maturity to buyers.

Build toward a 3-4 physician group. Solo and two-physician OB/GYN practices face steep discounts because of call coverage fragility. Adding even one provider transforms the call structure and the multiple.

Document your referral relationships.Buyers want to see that patient volume is driven by an established referral network from PCPs, midwives, and the community — not just the selling physician's personal reputation.

The Bottom Line

OB/GYN practice valuation is shaped by factors that don't exist in most other specialties — delivery volume, malpractice exposure, call coverage logistics, and hospital strategic interest. The practices that command premium multiples are those that have built sustainable call structures, captured ancillary revenue in-house, and positioned themselves as essential to a hospital system's women's health strategy. If you're thinking about selling, start with those fundamentals and everything else follows.